Loading...

AMPH AMPHASTAR PHARMACEUTICALS INC Company Mergers 8-K Filing

MPHS

MPH

AMPHASTAR PHARMACEUTICALS INC

(AMPH)

2025 8-K

Show Summary

Summary

New Research Agreement

Financial Statements

Financial Statements

Financial Results

Q3 Earnings Report

Distribution Agreement

Financial Results Announcement

Annual Meeting and Share Bu...

Earnings Reports

Financial Results Announcement

Earnings Report

Purchase Agreement

Financial Results Announcement

Credit Agreement and Acquis...

Annual Meeting Voting Results

Financial Results Announcement

Asset Purchase Agreement

Amendment to Contract Resea...

Financial Results Announcement

Amended and Restated Bylaws...

External Links:

On September 15, 2025, Amphastar Pharmaceuticals signed a $2.8 million agreement with Nanjing Hanxin Pharmaceutical to develop proprietary cell banks for their product AMP-107. The contract includes various licensing terms and requires payments in Chinese yuan.

AI Assistant

AMPHASTAR PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.